AG真人官方

Michael Carlet, Chief Financial Officer of Resideo Technologies, Inc. (REZI), reported a sale of 2,334 shares of the company's common stock on 08/15/2025 at a price of $31.60 per share. Following this transaction he beneficially owned 158,527 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025.

CD&R Channel Holdings II, L.P. reported purchases of Resideo Technologies, Inc. (REZI) common stock on three dates in August 2025. The filer acquired 203,161 shares on 08/14/2025 at a weighted average price of $31.8884 (range $31.635鈥�$32.00), 339,863 shares on 08/15/2025 at $31.4172 (range $31.045鈥�$32.00) and 111,000 shares on 08/18/2025 at $31.6568 (range $31.37鈥�$31.855). Following these transactions, the reported beneficial ownership held indirectly by the reporting group totaled 12,132,567 shares. The filing clarifies that the securities are directly owned by CD&R Channel Holdings II, L.P., with related entities and an investment committee described as potentially benefitting from or making decisions about the holdings, and that the reported prices are weighted averages across multiple trades.

Clayton, Dubilier & Rice (CD&R) reported an 18.3% beneficial stake in Resideo Technologies (Common Stock) through related Cayman entities. The filing shows CD&R Channel Holdings II, L.P. directly holds 12,132,567 shares and 498,500 shares of Series A Preferred Stock held by CD&R Channel Holdings are convertible into 18,517,830 common shares at an initial conversion price of $26.92, producing an aggregate reported beneficial ownership of 30,650,397 shares, equal to 18.3% of a 167,281,233 share base used for calculation. CD&R Channel Holdings alone is reported as owning an 11.1% as-converted interest. The amendment discloses recent open-market purchases by CD&R Holdings II on multiple dates in August 2025 totaling several hundred thousand shares at prices ranging roughly from $27.08 to $32.00. The filing includes an undertaking to provide detailed per-price purchase data to the issuer or the SEC staff.

Resideo Technologies insider sale: Jay L. Geldmacher, who serves as President and CEO and is also a director, reported the sale of 47,500 shares of Resideo common stock on 08/12/2025. The shares were sold in multiple transactions at prices ranging from $30.82 to $31.44, producing a weighted-average price of $31.2902. After the sale, Geldmacher beneficially owned 519,689 shares. The Form 4 was signed by an attorney-in-fact, Jeannine J. Lane, on 08/14/2025. The filing records a direct disposition and does not include derivative transactions.

Insider exercise and share withholding by Resideo executive. Stephen M. Kelly, EVP and Chief HR Officer of Resideo Technologies (REZI), reported option activity on 08/12/2025. He exercised fully vested stock options with a $24.39 exercise price for 38,053 shares; the filing shows those options were exercisable through 02/10/2026. To satisfy the exercise price and tax withholding, the issuer withheld 32,970 shares at an implied price of $31.28. After these transactions the report lists 233,289 shares beneficially owned by Mr. Kelly (direct ownership). The option grant that produced the exercised shares is described as fully vested, and the Form 4 was signed by an attorney-in-fact on 08/14/2025.

Jeannine J. Lane, Resideo Technologies (REZI) EVP, General Counsel and Corporate Secretary, reported option exercise and contemporaneous sale on 08/12/2025. The filing shows Lane exercised a stock option with a $24.39 exercise price for 35,398 shares and immediately sold 35,398 shares at a weighted average price of $31.312. After these transactions, the filing reports Lane beneficially owned 155,136 shares (down from 190,534 before the sale); the prior balance included 352 shares that were omitted in earlier Form 4s. The Form notes the option was fully vested and provides the sale price range of $31.31 to $31.345.

Resideo Technologies completed a transaction that terminated a long鈥憇tanding indemnification and reimbursement arrangement with Honeywell in exchange for a one鈥憈ime $1,590,000,000 cash payment. The termination eliminated Resideo鈥檚 obligation to make annual payments to Honeywell of up to $140 million through year鈥慹nd 2043 and removed the affirmative and negative covenants under that agreement, subject only to limited provisions that survived termination.

To fund part of the payment, Resideo amended its existing credit facilities and obtained incremental senior secured term loans totaling $1.225 billion with a seven鈥憏ear maturity and interest at Term SOFR plus 2.00%. The amendment also raised the interest on certain existing term B tranches from Term SOFR plus 1.75% to Term SOFR plus 2.00%, increased capacity to incur incremental debt, temporarily relaxed the total leverage covenant to 4.00:1.00 for two upcoming test periods, and permits future revolver refinancings.

Resideo Technologies insider transaction summary The Form 4 reports that CD&R-affiliated entities, identified as a director and greater-than-10% owner, purchased a total of 1,246,123 shares of Resideo Technologies, Inc. (REZI) across transactions dated 08/08/2025, 08/11/2025 and 08/12/2025. The filing shows weighted-average prices for the five reported lots of $27.3003, $27.3366, $30.0345, $30.9423 and $31.4902, and footnotes disclose the price ranges for each lot.

Following these purchases the reporting persons' disclosed beneficial ownership rose to 11,478,543 shares. The securities are owned directly by CD&R Channel Holdings II, L.P., with CD&R Investment Associates XII, Ltd. and CD&R Associates XII, L.P. identified as affiliated entities that may be deemed to beneficially own the reported securities.

Resideo Technologies insider filing: Michael Carlet, the company's Chief Financial Officer, reported a purchase of 1,540 shares of Resideo Technologies, Inc. (REZI) on 08/09/2025 at a reported price of $27.37 per share. Following the transaction his beneficial ownership is reported as 160,861 shares. The transaction is recorded on a Form 4 and is shown with transaction code F.